BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27283448)

  • 1. Development of Simplified Heterocyclic Acetogenin Analogues as Potent and Selective Trypanosoma brucei Inhibitors.
    Florence GJ; Fraser AL; Gould ER; King EF; Menzies SK; Morris JC; Thomson MI; Tulloch LB; Zacharova MK; Smith TK
    ChemMedChem; 2016 Jul; 11(14):1503-6. PubMed ID: 27283448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-natural acetogenin analogues as potent Trypanosoma brucei inhibitors.
    Florence GJ; Fraser AL; Gould ER; King EF; Menzies SK; Morris JC; Tulloch LB; Smith TK
    ChemMedChem; 2014 Nov; 9(11):2548-56. PubMed ID: 25145275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplifying nature: Towards the design of broad spectrum kinetoplastid inhibitors, inspired by acetogenins.
    Gould ER; King EFB; Menzies SK; Fraser AL; Tulloch LB; Zacharova MK; Smith TK; Florence GJ
    Bioorg Med Chem; 2017 Nov; 25(22):6126-6136. PubMed ID: 28185724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Synthesis of Broad Spectrum Trypanosomatid Selective Inhibitors.
    Fraser AL; Menzies SK; King EFB; Tulloch LB; Gould ER; Zacharova MK; Smith TK; Florence GJ
    ACS Infect Dis; 2018 Apr; 4(4):560-567. PubMed ID: 29313667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of cyclic tetrapeptoid analogues of the antiprotozoal natural product apicidin.
    Murray PJ; Kranz M; Ladlow M; Taylor S; Berst F; Holmes AB; Keavey KN; Jaxa-Chamiec A; Seale PW; Stead P; Upton RJ; Croft SL; Clegg W; Elsegood MR
    Bioorg Med Chem Lett; 2001 Mar; 11(6):773-6. PubMed ID: 11277517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photo-affinity labelling and biochemical analyses identify the target of trypanocidal simplified natural product analogues.
    Tulloch LB; Menzies SK; Fraser AL; Gould ER; King EF; Zacharova MK; Florence GJ; Smith TK
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005886. PubMed ID: 28873407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of CTP synthetase inhibitors as potential agents for the treatment of African trypanosomiasis.
    Tamborini L; Pinto A; Smith TK; Major LL; Iannuzzi MC; Cosconati S; Marinelli L; Novellino E; Lo Presti L; Wong PE; Barrett MP; De Micheli C; Conti P
    ChemMedChem; 2012 Sep; 7(9):1623-34. PubMed ID: 22865834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.
    Smith TK; Crossman A; Brimacombe JS; Ferguson MA
    EMBO J; 2004 Nov; 23(23):4701-8. PubMed ID: 15526036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead.
    Chauvière G; Bouteille B; Enanga B; de Albuquerque C; Croft SL; Dumas M; Périé J
    J Med Chem; 2003 Jan; 46(3):427-40. PubMed ID: 12540242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolylisoxazoles: potent inhibitors of prolyloligopeptidase with antitrypanosomal activity.
    Bal G; Van der Veken P; Antonov D; Lambeir AM; Grellier P; Croft SL; Augustyns K; Haemers A
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2875-8. PubMed ID: 14611847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
    Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
    Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereospecific synthesis of chiral 2,3-dihydro-1,4-benzodithiine and methyl-2,3-dihydro-1,4-benzodithiine derivatives and their toxic effects on Trypanosoma brucei.
    Ali Shah ST; Merkel P; Ragge H; Duszenko M; Rademann J; Voelter W
    Chembiochem; 2005 Aug; 6(8):1438-41. PubMed ID: 16052614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
    Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.
    Kelly JM; Taylor MC; Horn D; Loza E; Kalvinsh I; Björkling F
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1886-90. PubMed ID: 22326398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huprines as a new family of dual acting trypanocidal-antiplasmodial agents.
    Defaux J; Sala M; Formosa X; Galdeano C; Taylor MC; Alobaid WA; Kelly JM; Wright CW; Camps P; Muñoz-Torrero D
    Bioorg Med Chem; 2011 Mar; 19(5):1702-7. PubMed ID: 21315611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
    Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
    Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.
    Woodland A; Grimaldi R; Luksch T; Cleghorn LA; Ojo KK; Van Voorhis WC; Brenk R; Frearson JA; Gilbert IH; Wyatt PG
    ChemMedChem; 2013 Jul; 8(7):1127-37. PubMed ID: 23776181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.